Precigen price target raised to $18 from $14 at H.C. Wainwright
very_bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
very_bullish
What happened, with direct paths to the underlying reporting
H.C. Wainwright lifts Precigen (PGEN) target to $18 from $14. Current price: $6.53. The upgrade implies substantial upside potential and a very bullish setup.
Target: $18
Posted price: $6.53
Analyst firm: H.C. Wainwright
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.